Cargando…

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)

Detalles Bibliográficos
Autores principales:	Liu, Lisa, Yang, Qianli, Su, Ming-wan, Zhou, Youwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491801/ https://www.ncbi.nlm.nih.gov/pubmed/37693929 http://dx.doi.org/10.1016/j.jdcr.2023.06.051

Ejemplares similares

IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis
por: Vu, Yen Hai, et al.
Publicado: (2020)

Tapinarof for the treatment of psoriasis
por: Nogueira, Sofia, et al.
Publicado: (2022)

Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022)

Detection of aryl hydrocarbon receptor agonists in human samples
por: Rothhammer, Veit, et al.
Publicado: (2018)

Vitiligo patients show significant up-regulation of aryl hydrocarbon receptor transcription factor
por: Behfarjam, Farinaze, et al.
Publicado: (2018)

The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
por: O'Donnell, Edmond F., et al.
Publicado: (2010)

Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
por: Rothhammer, Veit, et al.
Publicado: (2017)

Correction: Tapinarof Cream 1%: First Approval
por: Keam, Susan J.
Publicado: (2022)

Discovery of 2-aryl and 2-pyridinylbenzothiazoles endowed with antimicrobial and aryl hydrocarbon receptor agonistic activities
por: Goya-Jorge, Elizabeth, et al.
Publicado: (2020)

Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
por: Zhang, Shu, et al.
Publicado: (2003)

Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis
por: Harrill, Joshua A, et al.
Publicado: (2015)

Characterization of Natural Aryl Hydrocarbon Receptor Agonists from Cassia Seed and Rosemary
por: Amakura, Yoshiaki, et al.
Publicado: (2014)

Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
por: Spencer, Riley K, et al.
Publicado: (2023)

Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells
por: Hanieh, Hamza, et al.
Publicado: (2016)

Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
por: Abdullah, Alzahrani, et al.
Publicado: (2019)

Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS
por: Tsaktanis, Thanos, et al.
Publicado: (2020)

Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice
por: Zapadka, Thomas E., et al.
Publicado: (2021)

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
por: Howard, Gregory J., et al.
Publicado: (2010)

Nonulcerated Necrobiosis Lipoidica Successfully Treated with Tapinarof: A Case Report
por: Palomares, Samantha J, et al.
Publicado: (2023)

First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report
por: ISSA, Naiem T., et al.
Publicado: (2023)

Synergistic Embryotoxicity of Polycyclic Aromatic Hydrocarbon Aryl Hydrocarbon Receptor Agonists with Cytochrome P4501A Inhibitors in Fundulus heteroclitus
por: Wassenberg, Deena M., et al.
Publicado: (2004)

Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization
por: Vyhlídalová, Barbora, et al.
Publicado: (2020)

Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
Publicado: (2019)

Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
por: Chen, Jiaxuan, et al.
Publicado: (2020)

Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis
por: Zhu, Renfei, et al.
Publicado: (2018)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

Antioxidant Functions of the Aryl Hydrocarbon Receptor
por: Dietrich, Cornelia
Publicado: (2016)

Aryl Hydrocarbon Receptor and Stem Cells
por: Gasiewicz, Thomas A., et al.
Publicado: (2017)

The Aryl Hydrocarbon Receptor and Tumor Immunity
por: Xue, Ping, et al.
Publicado: (2018)

The Aryl Hydrocarbon Receptor and the Nervous System
por: Juricek, Ludmila, et al.
Publicado: (2018)

The aryl hydrocarbon receptor in liver inflammation
por: Carambia, Antonella, et al.
Publicado: (2021)

Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
por: Yang, Qianli, et al.
Publicado: (2021)

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
por: Ciolino, H P, et al.
Publicado: (1999)

Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
por: Veldhoen, Marc, et al.
Publicado: (2009)

Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
por: Prud'homme, Gérald J., et al.
Publicado: (2010)

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma
por: Slominski, Andrzej T., et al.
Publicado: (2023)

Clustering Infertile Couples With Dyadic Approach: WHO-5-WBI as a Promising Tool for Assessing Psychological State
por: Hegyi, Borbála Eszter, et al.
Publicado: (2020)

Activation of the aryl hydrocarbon receptor inhibits neuropilin-1 upregulation on IL-2-responding CD4(+) T cells
por: Sandoval, Simone, et al.
Publicado: (2023)

Reciprocal regulation of interleukin-17A and interleukin-22 secretion through aryl hydrocarbon receptor activation in CD4(+) T cells of patients with vitiligo
por: Liu, Baoyi, et al.
Publicado: (2021)

AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2‐STAT3 signaling pathway
por: Zhang, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0rqivn2fcbhh1nrnucu5p02ccd